Medivir Competitors and Similar CompaniesClear all

Medivir's competitors and similar companies include Anavex and Mirati Therapeutics.

	Medivir Medivir is a company that researches, develops, and sells pharmaceuticals primarily for the treatment of oncology.	Anavex Anavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases.	Mirati Therapeutics Mirati Therapeutics is an oncology company that designs and develops targeted therapies to address the genetic drivers of cancer.
Founding Date	Founding Date 1988	Founding Date 2006	Founding Date 2013
Type	Type Public	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech clinical research drug development oncology pharma therapy	Tags Healthcare biotech clinical research drug development healthtech life sciences oncology pharma therapy	Tags Healthcare biotech clinical research drug development oncology therapy
Locations	Locations Huddinge, SE HQ	Locations New York, US HQ Reno, US	Locations San Diego, US HQ Zug, CH
Employees	Employees 9	Employees 1623% increase	Employees 666% decrease
Valuation ($)	Valuation ($) 39.2 m	Valuation ($) 484.6 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) kr8.5m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $12.4m (FY, 2022)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $600k (FY, 2022)
Gross profit	Gross profit kr8.5m (FY, 2025)	Gross profit N/A	Gross profit $11.8m (FY, 2022)
Net income	Net income (kr94.4m) (FY, 2025)	Net income ($46.4m) (FY, 2025)	Net income ($740.9m) (FY, 2022)

For sources of this data, please see the company profile

New York, US

Employees

16↑ 23% increase

Anavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases.

San Diego, US

Mirati Therapeutics is an oncology company that designs and develops targeted therapies to address the genetic drivers of cancer.

Financial